Envoy Medical (COCH) Profit After Tax (2021 - 2026)

Envoy Medical has disclosed Profit After Tax across 6 years of filings, most recently posting -$7.3 million for Q2 2026.

• In Q2 2026, Profit After Tax fell 4.75% year-over-year to -$7.3 million; the TTM figure through Jun 2026 stood at -$27.1 million (down 0.52% YoY), while the FY2025 annual figure was -$28.7 million, down 2.46% from the prior year.
• Profit After Tax came in at -$7.3 million for Q2 2026 at Envoy Medical, down from -$4.4 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $1.6 million in Q3 2023 to a low of -$13.3 million in Q2 2023.
• Average Profit After Tax over 5 years is -$6.2 million, with a median of -$6.6 million recorded in 2024.
• The largest YoY upside for Profit After Tax was 216.47% in 2023 against a maximum downside of 979.05% in 2023.
• Over 5 years, Profit After Tax stood at -$11.5 million in 2022, then soared by 45.62% to -$6.2 million in 2023, then decreased by 23.11% to -$7.7 million in 2024, then slipped by 0.66% to -$7.7 million in 2025, then gained by 6.01% to -$7.3 million in 2026.
• Per Business Quant data, the three most recent Profit After Tax figures were -$7.3 million in Q2 2026, -$4.4 million in Q1 2026, and -$7.7 million in Q4 2025.